|1.||Zhou, Wenbo: 1 article (07/2015)|
|2.||Lee, Ju Hee: 1 article (07/2015)|
|3.||Kim, Hyun Pyo: 1 article (07/2015)|
|4.||Ahn, Jongmin: 1 article (07/2015)|
|5.||Kim, Jin Woong: 1 article (07/2015)|
|6.||Nie, Xiuhong: 1 article (07/2015)|
|7.||Lee, Sang Gook: 1 article (07/2015)|
|8.||Jung, Eunsun: 1 article (01/2013)|
|9.||Kim, Jang-Hyun: 1 article (01/2013)|
|10.||Kim, Eui-Gyun: 1 article (01/2013)|
|1.||Asthma (Bronchial Asthma)
07/01/2015 - "To investigate the anti-asthmatic potential of afzelin, as well as the underlying mechanisms involved, its anti-asthmatic potential were investigated in a murine model of asthma. "
07/01/2015 - "Afzelin attenuates asthma phenotypes by downregulation of GATA3 in a murine model of asthma."
07/01/2015 - "The effect of afzelin on airway hyperresponsiveness, eosinophilic infiltration, Th2 cytokine and OVA‑specific IgE production in a mouse model of asthma were investigated. "
07/01/2015 - "The results of the present study suggested that the therapeutic mechanism by which afzelin effectively treats asthma is based on reduction of Th2 cytokine via inhibition of GATA-binding protein 3 transcription factor, which is the master regulator of Th2 cytokine differentiation and production."
|2.||Phototoxic Dermatitis (Phototoxicity)
|1.||Transcription Factors (Transcription Factor)
|2.||Carrier Proteins (Binding Protein)
|3.||Immunoglobulin E (IgE)